$20.00
-0.03-0.15%
At Close: -
$20.00
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
BioLife Solns
BLFSNASDAQ
BioLife Solns (NASDAQ:BLFS) Stock, Analyst Ratings, Price Targets, Forecasts
BioLife Solutions Inc has a consensus price target of $25.88 based on the ratings of 13 analysis. The 3 most-recent analyst ratings were released by Benchmark, Jefferies, and Craig-Hallum on May 13, 2024, April 4, 2024, and August 10, 2023, respectively. With an average price target of $23.33 between Benchmark, Jefferies, and Craig-Hallum, there's an implied 16.67% upside for BioLife Solutions Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Jefferies
Craig-Hallum
TD Cowen
Lake Street
1calculated from analyst ratings
Analyst Ratings for BioLife Solns
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | Buy Now | 25% | Benchmark | Robert Wasserman | → $25 | Upgrade | Hold → Buy | Get Alert |
| 04/04/2024 | Buy Now | 10% | Jefferies | Matthew Stanton | → $22 | Initiates | → Buy | Get Alert |
| 08/10/2023 | Buy Now | 15% | Craig-Hallum | Matt Hewitt | $29 → $23 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | 25% | TD Cowen | Max Masucci | $29 → $25 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | 25% | Lake Street | Thomas Flaten | $34 → $25 | Maintains | Buy | Get Alert |
| 07/17/2023 | Buy Now | 45% | Stephens & Co. | Jacob Johnson | $27 → $29 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 45% | Craig-Hallum | Matt Hewitt | → $29 | Initiates | → Buy | Get Alert |
| 03/17/2023 | Buy Now | 35% | Stephens & Co. | Jacob Johnson | $31 → $27 | Maintains | Overweight | Get Alert |
| 03/06/2023 | Buy Now | 40% | Oppenheimer | Suraj Kalia | → $28 | Reiterates | → Outperform | Get Alert |
| 05/10/2022 | Buy Now | 100% | Stephens & Co. | Jacob Johnson | $47 → $40 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 50% | Keybanc | Paul Knight | $60 → $30 | Maintains | Overweight | Get Alert |
| 04/25/2022 | Buy Now | 40% | Oppenheimer | Suraj Kalia | → $28 | Upgrade | Perform → Outperform | Get Alert |
| 08/13/2021 | Buy Now | 200% | Keybanc | Paul Knight | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for BioLife Solns (BLFS) stock?
The latest price target for BioLife Solns (NASDAQ:BLFS) was reported by Benchmark on May 13, 2024. The analyst firm set a price target for $25.00 expecting BLFS to rise to within 12 months (a possible 25.00% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioLife Solns (BLFS)?
The latest analyst rating for BioLife Solns (NASDAQ:BLFS) was provided by Benchmark, and BioLife Solns upgraded their buy rating.
When was the last upgrade for BioLife Solns (BLFS)?
The last upgrade for BioLife Solutions Inc happened on May 13, 2024 when Benchmark raised their price target to $25. Benchmark previously had a hold for BioLife Solutions Inc.
When was the last downgrade for BioLife Solns (BLFS)?
There is no last downgrade for BioLife Solns.
When is the next analyst rating going to be posted or updated for BioLife Solns (BLFS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioLife Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioLife Solns was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
Is the Analyst Rating BioLife Solns (BLFS) correct?
While ratings are subjective and will change, the latest BioLife Solns (BLFS) rating was a upgraded with a price target of $0.00 to $25.00. The current price BioLife Solns (BLFS) is trading at is $20.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.